| Name | sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
| Description | Enables sphingomyelin phosphodiesterase activity. Involved in sphingomyelin catabolic process. Predicted to be located in plasma membrane. Predicted to be active in cytoplasm. Biomarker of pulmonary emphysema. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSMPD3 encodes neutral sphingomyelinase 2 (nSMase2), a key enzyme that hydrolyzes sphingomyelin into the bioactive lipid ceramide. Ceramide in turn functions as an important second messenger that regulates stress‐induced signaling, apoptosis, cell cycle arrest, and exosome biogenesis. nSMase2 activity is tightly controlled by multiple regulatory mechanisms – it is dependent on Mg²⁺ and is activated by phosphatidylserine through conformational re‐arrangements (including a critical “DK switch”) and interdomain interactions. In addition, nSMase2 is modulated by post‐translational modifications such as phosphorylation (which can be rapidly altered via kinases like p38 MAPK and protein kinase Cs, and reversed by calcineurin) and is transcriptionally induced by stress signals including p53 activation and all‐trans retinoic acid, a process that involves specific promoter elements and histone acetylation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn cancer and developmental contexts, nSMase2‐generated ceramide has been shown to drive the secretion of ceramide‐rich exosomes that convey microRNAs between cells, thereby promoting angiogenesis and metastasis. In response to pro‐inflammatory cytokines such as tumor necrosis factor‐α, nSMase2 translocates to the plasma membrane to enhance the expression of adhesion molecules that aid in cell–cell interactions. Moreover, loss‐of‐function mutations or deletions in the SMPD3 gene have been implicated in oncogenic processes including leukemias, while proper nSMase2 activity is essential for neuroprogenitor ciliogenesis through the regulation of signaling cascades involving atypical protein kinase C and HDAC6."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in cancer, SMPD3 influences a broad spectrum of metabolic, vascular, and immune cell functions. In the intestine, for example, nSMase2 is transcriptionally regulated by the farnesoid X receptor to alter ceramide synthesis, thereby modulating atherosclerotic processes. Endothelial cells respond to low concentrations of oxidized lipoproteins by engaging nSMase2/sphingosine kinase‐1 signaling to promote angiogenesis, and nSMase2 regulates the extracellular release of microRNAs. In hepatocytes, palmitic acid triggers nSMase2 palmitoylation and plasma membrane translocation, leading to local ceramide generation and the onset of insulin resistance. In immune cells, nSMase2 plays roles in T cell receptor signaling and metabolic reprogramming (including association with lipid droplets) and has even been linked to altered cytokine responses in autoimmune conditions such as systemic lupus erythematosus. Furthermore, nSMase2 has been implicated in triggering inflammatory cascades through regulation of IRAK‐1 degradation and mediating uPA‐stimulated mitogenic signaling, as well as in promoting the cytodifferentiation of periodontal ligament cells. Finally, altered SMPD3 expression has been associated with neuropsychiatric features, bone mineralization deficits, and vascular calcification, and emerging small‐molecule inhibitors targeting nSMase2 offer novel therapeutic avenues."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "14", "end_ref": "27"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Norma Marchesini, Chiara Luberto, Yusuf A Hannun "}, {"type": "b", "children": [{"type": "t", "text": "Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M212262200"}], "href": "https://doi.org/10.1074/jbc.M212262200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12566438"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12566438"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Hiromi Ito, Masashi Murakami, Ayako Furuhata, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbagrm.2009.08.006"}], "href": "https://doi.org/10.1016/j.bbagrm.2009.08.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19698806"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19698806"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Simone Filosto, William Fry, Anne A Knowlton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neutral sphingomyelinase 2 (nSMase2) is a phosphoprotein regulated by calcineurin (PP2B)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.069963"}], "href": "https://doi.org/10.1074/jbc.M109.069963"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20106976"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20106976"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Christopher J Clarke, Krutika Mediwala, Russell W Jenkins, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neutral sphingomyelinase-2 mediates growth arrest by retinoic acid through modulation of ribosomal S6 kinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.193375"}], "href": "https://doi.org/10.1074/jbc.M110.193375"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21536668"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21536668"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Achraf A Shamseddine, Michael V Airola, Yusuf A Hannun "}, {"type": "b", "children": [{"type": "t", "text": "Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Adv Biol Regul (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jbior.2014.10.002"}], "href": "https://doi.org/10.1016/j.jbior.2014.10.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25465297"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25465297"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "A A Shamseddine, C J Clarke, B Carroll, et al. "}, {"type": "b", "children": [{"type": "t", "text": "P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2015.268"}], "href": "https://doi.org/10.1038/cddis.2015.268"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26512957"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26512957"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Michael V Airola, Prajna Shanbhogue, Achraf A Shamseddine, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1705134114"}], "href": "https://doi.org/10.1073/pnas.1705134114"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28652336"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28652336"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Prajna Shanbhogue, Reece M Hoffmann, Michael V Airola, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The juxtamembrane linker in neutral sphingomyelinase-2 functions as an intramolecular allosteric switch that activates the enzyme."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA118.007288"}], "href": "https://doi.org/10.1074/jbc.RA118.007288"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30890560"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30890560"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Motohiro Tani, Yusuf A Hannun "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of membrane topology of neutral sphingomyelinase 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2007.02.046"}], "href": "https://doi.org/10.1016/j.febslet.2007.02.046"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17349629"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17349629"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Woo Jae Kim, Ross A Okimoto, Louise E Purton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2007-10-113068"}], "href": "https://doi.org/10.1182/blood-2007-10-113068"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18299447"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18299447"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Christopher J Clarke, Emily A Cloessner, Patrick L Roddy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-α in MCF-7 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20101752"}], "href": "https://doi.org/10.1042/BJ20101752"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21303347"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21303347"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Nobuyoshi Kosaka, Haruhisa Iguchi, Keitaro Hagiwara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.446831"}], "href": "https://doi.org/10.1074/jbc.M112.446831"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23439645"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23439645"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Anne Montfort, Florie Bertrand, Julia Rochotte, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Immunol Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/2326-6066.CIR-20-0342"}], "href": "https://doi.org/10.1158/2326-6066.CIR-20-0342"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33727246"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33727246"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Françoise Maupas-Schwalm, Aurélie Bedel, Nathalie Augé, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Integrin alpha(v)beta(3), metalloproteinases, and sphingomyelinase-2 mediate urokinase mitogenic effect."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2009.08.010"}], "href": "https://doi.org/10.1016/j.cellsig.2009.08.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19735728"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19735728"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Aneta Dobierzewska, Natalia V Giltiay, Sathish Sabapathi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein phosphatase 2A and neutral sphingomyelinase 2 regulate IRAK-1 protein ubiquitination and degradation in response to interleukin-1beta."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.238030"}], "href": "https://doi.org/10.1074/jbc.M111.238030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21708940"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21708940"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Christel Cinq-Frais, Christelle Coatrieux, Marie-Hélène Grazide, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbalip.2013.04.014"}], "href": "https://doi.org/10.1016/j.bbalip.2013.04.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23651497"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23651497"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Gergana Deevska, Manjula Sunkara, Claudia Karakashian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of procysteine on aging-associated changes in hepatic GSH and SMase: evidence for transcriptional regulation of smpd3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Lipid Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1194/jlr.M048223"}], "href": "https://doi.org/10.1194/jlr.M048223"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25047167"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25047167"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Shiori Kubota, Mitsuru Chiba, Miki Watanabe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Secretion of small/microRNAs including miR-638 into extracellular spaces by sphingomyelin phosphodiesterase 3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2014.3605"}], "href": "https://doi.org/10.3892/or.2014.3605"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25394686"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25394686"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Caroline Camaré, Nathalie Augé, Mélanie Pucelle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The neutral sphingomyelinase-2 is involved in angiogenic signaling triggered by oxidized LDL."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Free Radic Biol Med (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.freeradbiomed.2016.02.006"}], "href": "https://doi.org/10.1016/j.freeradbiomed.2016.02.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26855418"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26855418"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "S Miyauchi, J Kitagaki, R Masumoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sphingomyelin Phosphodiesterase 3 Enhances Cytodifferentiation of Periodontal Ligament Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Dent Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/0022034516677938"}], "href": "https://doi.org/10.1177/0022034516677938"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28221099"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28221099"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "F Liu, X Li, H Yue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TLR-Induced SMPD3 Defects Enhance Inflammatory Response of B Cell and Macrophage in the Pathogenesis of SLE."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Scand J Immunol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/sji.12611"}], "href": "https://doi.org/10.1111/sji.12611"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28889482"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28889482"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Lena Collenburg, Sibylle Schneider-Schaulies, Elita Avota "}, {"type": "b", "children": [{"type": "t", "text": "The neutral sphingomyelinase 2 in T cell receptor signaling and polarity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Chem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1515/hsz-2017-0280"}], "href": "https://doi.org/10.1515/hsz-2017-0280"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29337691"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29337691"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Qing Wu, Lulu Sun, Xiaomin Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI142865"}], "href": "https://doi.org/10.1172/JCI142865"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33938457"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33938457"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Liubov S Kalinichenko, Christiane Mühle, Tianye Jia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41380-021-01304-w"}], "href": "https://doi.org/10.1038/s41380-021-01304-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34584229"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34584229"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Angelina Pavlic, Hessel Poelman, Grzegorz Wasilewski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of Neutral Sphingomyelinase 2 by Novel Small Molecule Inhibitors Results in Decreased Release of Extracellular Vesicles by Vascular Smooth Muscle Cells and Attenuated Calcification."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms24032027"}], "href": "https://doi.org/10.3390/ijms24032027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36768348"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36768348"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "S El-Amouri, A Karakashian, E Bieberich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulated translocation of neutral sphingomyelinase-2 to the plasma membrane drives insulin resistance in steatotic hepatocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Lipid Res (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jlr.2023.100435"}], "href": "https://doi.org/10.1016/j.jlr.2023.100435"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37640282"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37640282"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Rebekka Schempp, Janna Eilts, Marie Schöl, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Role of Neutral Sphingomyelinase-2 (NSM2) in the Control of Neutral Lipid Storage in T Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms25063247"}], "href": "https://doi.org/10.3390/ijms25063247"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38542220"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38542220"}]}]}]}
|
| Synonyms | NSMASE2 |
| Proteins | NSMA2_HUMAN |
| NCBI Gene ID | 55512 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SMPD3 has 6,652 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 125 datasets.
Click the + buttons to view associations for SMPD3 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by SMPD3 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SMPD3 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of SMPD3 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SMPD3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SMPD3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of SMPD3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SMPD3 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SMPD3 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SMPD3 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SMPD3 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of SMPD3 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SMPD3 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SMPD3 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with SMPD3 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SMPD3 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SMPD3 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SMPD3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SMPD3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SMPD3 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SMPD3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SMPD3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SMPD3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SMPD3 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SMPD3 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SMPD3 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SMPD3 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with SMPD3 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SMPD3 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SMPD3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SMPD3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SMPD3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SMPD3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for SMPD3 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SMPD3 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SMPD3 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SMPD3 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SMPD3 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with SMPD3 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with SMPD3 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SMPD3 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SMPD3 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SMPD3 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SMPD3 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SMPD3 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SMPD3 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SMPD3 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SMPD3 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SMPD3 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SMPD3 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SMPD3 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SMPD3 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SMPD3 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SMPD3 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by SMPD3 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by SMPD3 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of SMPD3 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SMPD3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SMPD3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SMPD3 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of SMPD3 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SMPD3 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with SMPD3 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with SMPD3 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SMPD3 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for SMPD3 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SMPD3 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SMPD3 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SMPD3 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SMPD3 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for SMPD3 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with SMPD3 gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with SMPD3 gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with SMPD3 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with SMPD3 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| HumanCyc Pathways | pathways involving SMPD3 protein from the HumanCyc Pathways dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SMPD3 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SMPD3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SMPD3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SMPD3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving SMPD3 protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving SMPD3 protein from the KEGG Pathways 2026 dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate SMPD3 protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SMPD3 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of SMPD3 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SMPD3 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SMPD3 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SMPD3 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SMPD3 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing SMPD3 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SMPD3 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SMPD3 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting SMPD3 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SMPD3 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of SMPD3 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by SMPD3 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SMPD3 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| MW Enzyme Metabolite Associations | interacting metabolites for SMPD3 protein from the MW Gene Metabolite Associations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of SMPD3 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SMPD3 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SMPD3 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SMPD3 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SMPD3 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SMPD3 protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with SMPD3 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PID Pathways | pathways involving SMPD3 protein from the PID Pathways dataset. | |
| Reactome Pathways 2014 | pathways involving SMPD3 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving SMPD3 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of SMPD3 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SMPD3 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SMPD3 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SMPD3 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SMPD3 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with SMPD3 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs | drug perturbations changing phosphorylation of SMPD3 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of SMPD3 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SMPD3 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SMPD3 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SMPD3 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SMPD3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SMPD3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SMPD3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SMPD3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SMPD3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SMPD3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving SMPD3 protein from the WikiPathways Pathways 2024 dataset. | |